Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease. (Q38069662)
Jump to navigation
Jump to search
scientific article published on 19 December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease. |
scientific article published on 19 December 2012 |
Statements
Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease (English)
human papilloma virus
1 reference
Kevin Harrington
Alain Berrier
Martin Robinson
Eva Remenar
Martin Housset
Fernando Hurtado de Mendoza
Jérôme Fayette
Iman El-Hariry
Natalie Compton
Natalie Franklin
Nigel Biswas-Baldwin
Mike Lau
Philippe Legenne
Rejnish Kumar
19 December 2012